Using a the gla−/− mutant ZF model, this study aims to unravel FD mechanisms associated with kidney damage related to α-Gal deficiency in the absence of Gb3 accumulation and identify novel markers of potential clinical relevance. This evidence concerns the gene GLA and Fabry disease.